Company news

Kalaris Therapeutics, Inc. news in 2026

Kalaris Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update

November 10, 2026

Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference

August 31, 2026

Kalaris Expands Leadership Team Appointing Liisa Bayko as Chief Financial Officer

July 20, 2026

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

July 17, 2026

Kalaris Appoints Laurie Keating to Board of Directors

July 6, 2026

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

June 22, 2026

Kalaris to Present at Clinical Trials at the Summit 2026

June 11, 2026

Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates

May 12, 2026

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

March 16, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

January 28, 2026

Decks in 2026